Serina Therapeutics Inc (SER)

Serina Therapeutics Revenue

Serina Therapeutics had revenue of $3.15M in the twelve months ending March 31, 2024, with 410.71% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.00K, a -83.33% decrease year-over-year. In the year 2023, Serina Therapeutics had annual revenue of $3.15M with 433.14% growth.

• Revenue (ttm): $3.15M
• Revenue Growth: +410.71%
• P/S Ratio: 26.72
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 84.14M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.15M	2.56M	433.14%
Dec 31, 2022	591.50K	447.50K	310.76%
Dec 31, 2021	144.00K	-217.00K	-60.11%
Dec 31, 2020	361.00K	-1.37M	-79.11%
Dec 31, 2019	1.73M	332.00K	23.78%
Dec 31, 2018	1.40M	-8.00K	-0.57%
Dec 31, 2017	1.40M	-262.00K	-15.73%
Dec 31, 2016	1.67M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.